Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-08-2021 | Head and Neck

Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years

Authors: Muhammad Faisal, Rahim Dhanani, Sami Ullah, Muhammad Abu Bakar, Nabia Irfan, Kashif Iqbal Malik, Asif Loya, Erovic M. Boban, Raza Hussain, Arif Jamshed

Published in: European Archives of Oto-Rhino-Laryngology | Issue 8/2021

Abstract

Objectives

To analyze the factors predicting survival outcomes in treatment naïve oral tongue squamous cell carcinoma (OTSCC).

Materials and methods

A comprehensive review of 531 oral tongue carcinoma patients treated with upfront surgery followed by adjuvant radiotherapy or chemoradiotherapy was conducted from 2004–2018.

Results

The mean age of presentation was 53 years (11–86) with a male to female ratio of 1.3:1. The associated risk factors were smoking (21%), betel nut (16%), naswar (9%) and alcohol (1%). Most of the cases were either well (45.1%) or moderately (46.2%) differentiated. Surgery was performed in 164 patients alone while 368 were treated with surgery in combination with adjuvant modalities. Overall (OS) and disease free survival (DFS) were 66 and 71%, respectively, with a median follow up of 2.5 years. Cox regression analysis showed nodal positivity, increased depth of invasion (DOI) and higher lymph node ratio (LNR) as significant prognosticators impacting OS and DSS.

Conclusion

Nodal volume, DOI and LNR are the most consistent predictors of poor outcome in OTSCC. Nodal positivity, depth of invasion > 5 mm and lymph node ratio > 0.04 adversely affect OS and DSS.

Marra A, Violati M, Broggio F, Codecà C, Blasi M, Luciani A et al (2019) Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study. Acta Otorhinolaryngol Ital 39(2):84CrossRefPubMedPubMedCentral

Patel SC, Carpenter WR, Tyree S, Couch ME, Weissler M, Hackman T et al (2011) Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 29(11):1488–1494CrossRefPubMed

Ng JH, Iyer NG, Tan MH, Edgren G (2017) Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck 39(2):297–304CrossRefPubMed

Bello IO, Soini Y, Salo T (2010) Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). Oral Oncol 46(9):636–643CrossRefPubMed

van Dijk BA, Brands MT, Geurts SM, Merkx MA, Roodenburg JL (2016) Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands. Int J Cancer 139(3):574–583CrossRefPubMed

Ram H, Sarkar J, Kumar H, Konwar R, Bhatt M, Mohammad S (2011) Oral cancer: risk factors and molecular pathogenesis. J Maxillofac Oral Surg 10(2):132CrossRefPubMedPubMedCentral

Han G, Xu C, Yu D (2018) Mechanisms correlated with chemotherapy resistance in tongue cancers. J Cancer Res Ther 14(1):1CrossRefPubMed

Bonnardot L, Bardet E, Steichen O, Cassagnau E, Piot B, Salam AP et al (2011) Prognostic factors for T1–T2 squamous cell carcinomas of the mobile tongue: a retrospective cohort study. Head Neck 33(7):928–934CrossRefPubMed

Cracchiolo JR, Xu B, Migliacci JC, Katabi N, Pfister DG, Lee NY et al (2018) Patterns of recurrence in oral tongue cancer with perineural invasion. Head Neck 40(6):1287–1295CrossRefPubMedPubMedCentral

10.

Maddox W, Sherlock E, Evans W (1971) Cancer of the tongue: review of thirteen-year experience–1955-1968. Am Surg 37(10):624–650PubMed

11.

Zelefsky MJ, Harrison LB, Fass DE, Armstrong J, Spiro RH, Shah JP et al (1990) Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome. Head Neck 12(6):470–475CrossRefPubMed

12.

D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373(6):521–529CrossRefPubMed

13.

Gregoire V, Lefebvre JL, Licitra L et al (2010) Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v184–v186CrossRefPubMed

14.

Rusthoven K, Ballonoff A, Raben D et al (2008) Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 112:345–351CrossRefPubMed

15.

Eurostat. Eurostat Statistics, Tobacco Consumption 2014 [5 February 2019]. Available from: https://ec.europa.eu/eurostat/statisticsexplained/index.php?title=Tobacco_consumption_statistics.

16.

Karnov KKS, Gronhoj C, Jensen DH, Wessel I, Charabi BW, Specht L et al (2017) Increasing incidence and survival in oral cancer: a nationwide Danish study from 1980 to 2014. Acta oncologica (Stockholm, Sweden). 56(9):1204–1209. https://doi.org/10.1080/0284186X.2017.1307516 (PMID: 28366106)CrossRef

17.

Tota JE, Anderson WF, Coffey C, Califano J, Cozen W, Ferris RL et al (2017) Rising incidence of oral tongue cancer among white men and women in the United States, 1973–2012. Oral Oncol 67:146–152. https://doi.org/10.1016/j.oraloncology.2017.02.019 (PMID: 28351569)CrossRefPubMed

18.

Bur AM, Lin A, Weinstein GS (2016) Adjuvant radiotherapy for early head and neck squamous cell carcinoma with perineural invasion: a systematic review. Head Neck 38(Suppl 1):E2350–E2357. https://doi.org/10.1002/hed.24295CrossRefPubMed

19.

Wu CS et al (2016) ASC contributes to metastasis of oral cavity squamous cell carcinoma. Oncotarget 7:50074–50085. https://doi.org/10.18632/oncotarget.10317CrossRefPubMedPubMedCentral

20.

Wreesmann VB et al (2016) Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head Neck 38(Suppl 1):E1192–E1199. https://doi.org/10.1002/hed.24190CrossRefPubMed

21.

Jerjes W et al (2010) Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1–T2 oral squamous cell carcinoma patients. Head Neck Oncol 2:9. https://doi.org/10.1186/1758-3284-2-9CrossRefPubMedPubMedCentral

22.

Hasegawa T et al (2015) Risk factors associated with distant metastasis in patients with oral squamous cell carcinoma. Otolaryngol Head Neck Surg 152:1053–1060. https://doi.org/10.1177/0194599815580980CrossRefPubMed

23.

Faisal M, Abu Bakar M, Sarwar A et al (2018) Depth of invasion (DOI) as a predictor of cervical nodal metastasis and local recurrence in early stage squamous cell carcinoma of oral tongue (ESSCOT). PLoS ONE 13(8):e0202632. https://doi.org/10.1371/journal.pone.0202632 (Published 2018 Aug 22)CrossRefPubMedPubMedCentral

24.

Huang SH, Hwang D, Lockwood G et al (2009) Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer 115:1489–1497. https://doi.org/10.1002/cncr.24161 (PMID: 19197973)CrossRefPubMed

25.

Keski Santti H, Atula T, Tornwall J et al (2006) Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol. 42(1):96–101. https://doi.org/10.1016/j.oraloncology.2005.06.018 (PMID: 16256414)CrossRefPubMed

26.

Kowalski LP, Medina JE (1998) Nodal metastases: predictive factors. Otolaryngol Clin North Am 31:621–637 (PMID: 9687325)CrossRefPubMed

27.

Melchers LJ, Schuuring E, van Dijk BA et al (2012) Tumour infiltration depth of 4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol 48:337–342. https://doi.org/10.1016/j.oraloncology.2011.11.007 (PMID: 22130455)CrossRefPubMed

28.

Patel SG, Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP et al (2013) Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research. Br J Cancer 109:2087–2095CrossRefPubMedPubMedCentral

29.

Wang YL, Feng SH, Zhu J, Zhu GP, Li DS, Wang Y et al (2013) Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis. PLoS ONE 8:e56613CrossRefPubMedPubMedCentral

30.

Wang YL, Zhu GP, Li DS, Wang Y, Wang ZY, Ji QH (2013) Lymph node ratio as a survival risk factor for oropharyngeal squamous cell carcinoma patients with lymph node metastasis: a surveillance, epidemiology and end results-based analysis. Head Neck Oncol 5(3):30

31.

Rudra S, Spiotto MT, Witt ME, Blair EA, Stenson K, Haraf DJ (2014) Lymph node density—prognostic value in head and neck cancer. Head Neck 36:266–272CrossRefPubMed

32.

Ong W, Zhao R, Lui B, Tan W, Ebrahimi A, Clark JR et al (2016) Prognostic significance of lymph node density in squamous cell carcinoma of the tongue. Head Neck 38(Suppl. 1):E859–E866CrossRefPubMed

33.

Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA et al (2015) Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck 37:777–782CrossRefPubMed

34.

Divi V, Harris J, Harari PM, Cooper JS, McHugh JB, Bell D, et al. Establishing quality indicators for neck dissection: correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501–0234. J Clin Oncol 2015;33. abstr 6011.

35.

Ding D, Stokes W, Eguchi M, Hararah M, Sumner W, Amini A, Goddard J, Somerset H, Bradley C, McDermott J, Raben D, Karam SD (2019) Association between lymph node ratio and recurrence and survival outcomes in patients with oral cavity cancer. JAMA Otolaryngol Head Neck Surg 145(1):53–61. https://doi.org/10.1001/jamaoto.2018.2974 (PMID:30452499;PMCID:PMC6439806)CrossRefPubMed

Title: Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years
Authors: Muhammad Faisal
Rahim Dhanani
Sami Ullah
Muhammad Abu Bakar
Nabia Irfan
Kashif Iqbal Malik
Asif Loya
Erovic M. Boban
Raza Hussain
Arif Jamshed
Publication date: 01-08-2021
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 8/2021
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-020-06482-x

At a glance: The STEP trials

Springer Medicine

Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years

Abstract

Objectives

Materials and methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Objectives

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2021

Decreased retinal nerve fiber and choroidal thickness in chronic rhinosinusitis

Identification and functional analysis of a novel missense mutation of PAX3 associated with Waardenburg syndrome type I

Sinonasal IgG4-related disease: a rare and emerging entity broadening the differential diagnosis in the sinonasal universe

Correction to: Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years

Endoscopic stapes surgery outcomes and complication rates: a systematic review

The change in tumor volume after induction chemotherapy with docetaxel plus cisplatin in 259 nasopharyngeal carcinoma patients